Brca1 Mutation Carrier Completed Phase 1 Trials for Veliparib (DB07232)

Also known as: BRCA1 Mutation Carrier

IndicationStatusPhase
DBCOND0030677 (Brca1 Mutation Carrier)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00892736Veliparib in Treating Patients With Malignant Solid Tumors That Do Not Respond to Previous TherapyTreatment
NCT01251874Veliparib and Carboplatin in Treating Patients With HER2-Negative Metastatic Breast CancerTreatment
NCT00535119Veliparib, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid CancerTreatment
NCT01154426ABT-888 and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid TumorsTreatment